检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:金陈进[1] 周立军 Jin Chenjin;Zhou Lijun(State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangzhou 510060,China)
机构地区:[1]中山大学中山眼科中心,眼科学国家重点实验室,510060
出 处:《中华眼底病杂志》2021年第8期585-588,共4页Chinese Journal of Ocular Fundus Diseases
基 金:广东省自然科学基金(2021A15150U106)。
摘 要:激光光凝在眼底疾病的治疗中一直发挥着重要作用。尽管近年来抗血管内皮生长因子药物被广泛应用,并逐渐成为一些眼底疾病的主要治疗方法,但临床实践证明其仍然不能替代激光光凝。而通过将两者有机联合、协同应用可获得更佳疗效。随着新技术的不断研发和加速转化,新的激光设备也不断推陈出新,朝着微创化、自动化及智能化发展。因此,我们仍有必要重视眼底激光光凝的临床应用,了解其进展和趋势,为患者提供更高水平的医疗服务。Laser photocoagulation has played an important role in the treatment of fundus diseases.Although anti-vascular endothelial growth factor drugs have been widely used in recent years and have gradually become the main therapy for some diseases,it still cannot substitute laser photocoagulation.A combination of anti-vascular endothelial growth factor and laser photocoagulation may optimize the treatment management and improve efficacy.With the development of technology,new laser equipment will certainly continue to appear and move towards minimally invasive automation and intellgentialization.Therefore,it is necessary for us to understand the current situation and trend of laser therapy in order to serve our patients better.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.70